Navigation Links
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer
Date:7/26/2009

Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that living with untreated cancer is not upsetting for many patients with early prostate cancer.

The rapid increase in the use of screening using prostate specific antigen (PSA) testing has led to a large number of men diagnosed with prostate cancer, many of who do not require treatment. In these cases, close clinical monitoringor active surveillanceis often recommended. If progression of the cancer occurs during active surveillance, patients may undergo radical therapy. While active surveillance may delay or even avoid the possible adverse side effects of radical treatment, it could also cause psychological harm in patients because they must live with untreated cancer. Data on the levels of such potentially negative emotions among men on active surveillance are lacking, however.

Roderick van den Bergh, (MD), of the Erasmus Medical Center, in Rotterdam, the Netherlands, and colleagues assessed levels of anxiety and distress in a group of recently diagnosed prostate cancer patients on active surveillance. They sent 150 men questionnaires to gauge uncertainty about their treatment decision, as well as levels of depression and anxiety among these men. A total of 129 questionnaires were completed and returned an average of 2.7 months after diagnosis. More than 80 percent of the 129 respondents scored favorably low on the parameters measured. Patients' scores were comparable or favorable to scores of men (reported in other studies) who underwent treatment for early prostate cancer.

Certain men in the studysuch as men with neurotic personalities and those who were in poor physical healthexhibited
'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Human cells secrete cancer-killing protein, UK study finds
2. Bone from blood: Circulating cells form bone outside the normal skeleton, Penn study finds
3. Case Western Reserve University receives $3.7M NIH grant to study autonomic nervous system link to painful bladder syndrome
4. Study finds rapid growth in health costs hurts economic performance of US industries
5. Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration
6. Study provides documentation that tumor stem-like cells exist in benign tumors
7. Major Study of Malpractice Insurance Finds No Basis to Limit Liability of Unsafe Health Care Providers
8. Eliminating Cell Receptor Prevents Infections in Animal Study
9. UC Davis study highlights work-life issues of female surgeons
10. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
11. AcelRx Announces Perfect Performance of Handheld Component of ARX-01 Sufentanil NanoTab PCA System in a Phase 2 Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
(Date:11/25/2009)...C sees few signs of trouble with the H1N1 vaccine,...) -- The ongoing H1N1 swine flu pandemic may be dr... younger patients, a U.S. health official said Wed... pneumococcal infections around the country," Dr. ... Immunization and Respiratory Diseases at the U.S....
(Date:11/25/2009)...ancer vaccine carried into the body on a carefully... to successfully eliminate tumors in mammals, scie...anslational Medicine . , The new approach, pione...University, uses plastic disks impregnated with tu... to reprogram the mammalian immune system to attac...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...e the risk of developing potentially harmful blood... center reported a case of 25 year old healthy mal... known as subdural haematomas, after riding severa...ath. It usually occurs in older men who are alcoho...
...rst forms of nightmare over the past 3 weeks , now...hreat of malaria . Malaria , not a new diseas...eas of Munger, 200 km (125 miles) southeast of the...te's health minister Mr.Shakuni Choudhary. Mr...
...itis, often grouped together under inflammatory bo...trialized nations with stringent standards of publ...ment prevents the human immune system from interac...tment regimen of worms may help patients with Croh...
...ed form of epidemic fevers, is spread by a virulen...ave 12 deaths (in the past fortnight) from leptosp...es in city hospitals, " Maharashtra state Health M... the patients come to public hospitals when their ...
...therapeutic challenge for many practising allopath...ine has taken its stride. Acupuncture vs massage f... practitioners. Dr. Dominik Irnich of Ludwig-Ma... in the short term. In his research which inclu...
...o autoimmune destruction of the pancreatic islet c... no longer produces insulin and and there is a rai...s type I Diabetes develop are at a higher risk to ...id a study involving 57 diabetics ages 12 to 21 an...
Other Medicine News:Health News:WORM! WORM! all the way 2
(Date:11/25/2009)...ewswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),a...minimallydisruptivesurgicaltreatmentsforthespine,a...,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfer...ementfortheCompany,sproductsandwillincludecomments...sion.Thedial-innumbersare1-877-407-4018fordomestic...
(Date:11/25/2009)...sandJOHANNESBURG,November25/PRNewswire/--,iThembaP...ouncedtoday,thattheyhavesignedacollaborativeagreem...Pyxis,sworldclasscomputationalchemistryandleaddisc...visiontoprovidemedicinaland,syntheticchemistrysupp...clientnetwork.iThembaPharmaceuticalsandPyxisDiscov...
(Date:11/24/2009)...RNewswire/-- ,, WHAT:RomHoubens,aBelgianmanthou...nt,wasactuallyfullyconsciousandawakeduringthattime...naVoxEyeMaxwasfeaturedinthesegmenttoillustratehowp...ockcommunication. ,, WHEN:GoodMorningAmerica-- ...xtech.com ,, WHO:RomHoubenswasanengineering...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2World Osteoporosis Day Call for Immediate Action to Prevent Fractures 14537 1World Osteoporosis Day Call for Immediate Action to Prevent Fractures 14537 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 1Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 5
...OUNTAIN VIEW, Calif., June 28 MAP,Pharmaceuticals...an in-vitro,study evaluating receptor pharmacology...) for the potential treatment of migraine, compare...among six posters relating,to the MAP0004 program ...e,Society 50th Annual Scientific Meeting in Boston...
...NDIANAPOLIS, June 27 Eli Lilly and Co (NYSE:,LLY)... Committee for,Medicinal Products for Human Use (C...ssued a positive opinion supporting the approval o...reatment of Generalised Anxiety,Disorder (GAD)., ...five clinical studies,-- four double-blind placebo...
Other Medicine Technology:MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 2MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 3MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 4European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 2European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 3European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 4European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 5European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 6
Near Point Card/Newspaper 8 to 48 - BC2203
Hart Card Set 2 Cards - BCHC
...es to many common print sizes, from newspaper head...s provides the examiner a starting point to determ...k on yellow styrene for increased contrast. It fea...otations include Jaeger, M notation, lower case po...
...g card was designed by James Lebensohn, MD and pro...ng words, numbers and OX symbols. Optotypes includ.../50, 20/40, 20/30, 20/25, and 20/20. Notation equi...ric, Jaeger, point size and visual efficiency perc...
Medicine Products: